Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 3Other hematologic neoplasm 2Gynecologic 2Tumor-Agnostic 1Plasma cell 1Myeloid 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Abiraterone Acetate 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × BID protein, human × Genitourinary × Clear all
NCT07090369 2025-07-29

LumOnate

Peter MacCallum Cancer Centre, Australia

Phase 1 Not yet recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting
400 enrolled
Genitourinary

Abiraterone Acetate

NCT00405210 2011-05-23

Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 1 Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡